Name | Number of supported studies | Average coverage | |
---|---|---|---|
renal alpha-intercalated cell | 7 studies | 60% ± 26% | |
ionocyte | 5 studies | 43% ± 8% | |
mast cell | 4 studies | 22% ± 8% | |
conventional dendritic cell | 4 studies | 21% ± 6% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of CLNK at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1383.88 | 89 / 89 | 14% | 8.83 | 128 / 901 |
lung | 89% | 39.84 | 517 / 578 | 18% | 0.36 | 210 / 1155 |
spleen | 100% | 239.37 | 241 / 241 | 0% | 0 | 0 / 0 |
prostate | 79% | 30.27 | 194 / 245 | 17% | 0.67 | 87 / 502 |
lymph node | 0% | 0 | 0 / 0 | 72% | 4.26 | 21 / 29 |
skin | 64% | 22.87 | 1161 / 1809 | 6% | 0.13 | 27 / 472 |
stomach | 58% | 16.86 | 209 / 359 | 8% | 0.22 | 24 / 286 |
thymus | 55% | 27.79 | 357 / 653 | 11% | 0.17 | 65 / 605 |
esophagus | 53% | 17.35 | 760 / 1445 | 10% | 0.17 | 18 / 183 |
intestine | 57% | 69.37 | 554 / 966 | 4% | 0.10 | 20 / 527 |
bladder | 52% | 16.90 | 11 / 21 | 4% | 0.08 | 19 / 504 |
adrenal gland | 53% | 11.11 | 136 / 258 | 3% | 0.07 | 7 / 230 |
peripheral blood | 47% | 384.28 | 432 / 929 | 0% | 0 | 0 / 0 |
uterus | 33% | 5.65 | 56 / 170 | 7% | 0.13 | 33 / 459 |
liver | 38% | 6.57 | 85 / 226 | 0% | 0.02 | 2 / 406 |
breast | 30% | 5.12 | 136 / 459 | 6% | 0.13 | 70 / 1118 |
pancreas | 28% | 22.72 | 91 / 328 | 6% | 0.10 | 11 / 178 |
adipose | 34% | 7.24 | 404 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 22% | 0.29 | 10 / 45 |
blood vessel | 19% | 6.06 | 255 / 1335 | 0% | 0 | 0 / 0 |
ovary | 14% | 2.26 | 26 / 180 | 1% | 0.01 | 4 / 430 |
brain | 9% | 1.65 | 250 / 2642 | 0% | 0.02 | 3 / 705 |
heart | 4% | 0.73 | 38 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.14 | 9 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043303 | Biological process | mast cell degranulation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0032815 | Biological process | negative regulation of natural killer cell activation |
GO_0002729 | Biological process | positive regulation of natural killer cell cytokine production |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0042629 | Cellular component | mast cell granule |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CLNK |
Protein name | Cytokine-dependent hematopoietic cell linker (Mast cell immunoreceptor signal transducer) Cytokine dependent hematopoietic cell linker |
Synonyms | MIST |
Description | FUNCTION: An adapter protein which plays a role in the regulation of immunoreceptor signaling, including PLC-gamma-mediated B-cell antigen receptor (BCR) signaling and FC-epsilon R1-mediated mast cell degranulation (By similarity). Together with FGR, it acts as a negative regulator of natural killer cell-activating receptors and inhibits interferon-gamma production (By similarity). Acts as a positive regulator of both T-cell receptor and natural killer T (NKT) cell receptor signaling in CD4-positive NKT cells (By similarity). Together with MAP4K1, it enhances CD3-triggered activation of T-cells and subsequent IL2 production (By similarity). May be involved in tumor necrosis factor induced cell death by promoting reactive oxidative species generation, and MLKL oligomerization, ultimately leading to necrosis (By similarity). Involved in phosphorylation of LAT (By similarity). May be involved in high affinity immunoglobulin epsilon receptor signaling in mast cells (By similarity). . |
Accessions | D6RJB9 Q7Z7G1 ENST00000515667.5 ENST00000226951.11 [Q7Z7G1-1] ENST00000507719.1 [Q7Z7G1-2] |